These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23056262)

  • 1. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
    Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
    PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
    Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
    BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
    Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPD.
    Lapperre TS; Willems LN; Timens W; Rabe KF; Hiemstra PS; Postma DS; Sterk PJ
    Chest; 2007 Jan; 131(1):53-9. PubMed ID: 17218556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in COPD.
    Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
    Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro.
    Babusyte A; Jeroch J; Stakauskas R; Stravinskaite K; Malakauskas K; Sakalauskas R
    Medicina (Kaunas); 2010; 46(5):315-22. PubMed ID: 20679746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
    Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
    COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
    Freeman CM; Crudgington S; Stolberg VR; Brown JP; Sonstein J; Alexis NE; Doerschuk CM; Basta PV; Carretta EE; Couper DJ; Hastie AT; Kaner RJ; O'Neal WK; Paine R; Rennard SI; Shimbo D; Woodruff PG; Zeidler M; Curtis JL
    J Transl Med; 2015 Jan; 13():19. PubMed ID: 25622723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary biomarkers in chronic obstructive pulmonary disease.
    Barnes PJ; Chowdhury B; Kharitonov SA; Magnussen H; Page CP; Postma D; Saetta M
    Am J Respir Crit Care Med; 2006 Jul; 174(1):6-14. PubMed ID: 16556692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
    Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
    J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD.
    Beeh KM; Beier J; Kornmann O; Mander A; Buhl R
    Chest; 2003 Mar; 123(3):778-83. PubMed ID: 12628878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.
    Rutgers SR; Timens W; Kaufmann HF; van der Mark TW; Koëter GH; Postma DS
    Eur Respir J; 2000 Jan; 15(1):109-15. PubMed ID: 10678630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
    Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
    Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Correlation Between Pulmonary and Systemic Inflammation Markers in Patients with Chronic Obstructive Pulmonary Disease: A Simultaneous, Two-Compartmental Analysis.
    Núñez B; Sauleda J; Garcia-Aymerich J; Noguera A; Monsó E; Gómez F; Barreiro E; Marín A; Antó JM; Agusti A;
    Arch Bronconeumol; 2016 Jul; 52(7):361-7. PubMed ID: 26921918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
    Keatings VM; Collins PD; Scott DM; Barnes PJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory markers for COPD in "susceptible" smokers.
    Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
    Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary disease.
    Bizeto L; Mazzolini AB; Ribeiro M; Stelmach R; Cukier A; Nunes MP
    Braz J Med Biol Res; 2008 Mar; 41(3):193-8. PubMed ID: 18327434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.